The Boeing Co. is one of the largest defense contractors in the U.S. for its premier jet aircraft along with varied defense products. Its customers include domestic & foreign airlines, the U.S. DoD, the Department of Homeland Security, the NASA, other aerospace prime contractors, and certain U.S. government and commercial communications customers. It has 4 segments. Boeing Commercial Airplanes Segment develops, produces & markets commercial jets, and support services. The 3 units that comprise the Boeing Defense, Space & Security (BDS) segment are as follows: Boeing Military Aircraft, Network and Space Systems and Global Services and Support. Boeing Global Services Segment brings together certain Commercial Aviation Services businesses and BDS businesses. It provides parts, maintenance, modifications, logistics support, training, data analytics and information-based services. Boeing Capital Corp. Segment provides selective financing solutions for BDS segment government customers....
+See More2022-03-25 09:34:00 Friday ET

Corporate cash management The empirical corporate finance literature suggests four primary motives for firms to hold cash. These motives include the tra
2019-09-23 12:25:00 Monday ET

Volcker, Greenspan, Bernanke, and Yellen contribute to a Wall Street Journal op-ed on monetary policy independence. These former Federal Reserve chiefs unit
2018-12-17 08:43:00 Monday ET

Apple files an appeal to overturn the recent iPhone sales ban in China due to its patent infringement of Qualcomm proprietary technology. This recent ban of
2023-02-07 08:26:00 Tuesday ET

Michel De Vroey delves into the global history of macroeconomic theories from real business cycles to persistent monetary effects. Michel De Vroey (2016)
2025-06-21 05:25:00 Saturday ET

President Trump refreshes American fiscal fears, worries, and concerns through the One Big Beautiful Bill Act. The Congressional Budget Office (CBO) estimat
2019-01-10 17:31:00 Thursday ET

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history. The resultant biopharma goliath would be